//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
"The Food and Drug Administration's top vaccine advisory committee voted unanimously today to recommend Moderna's mRNA influenza vaccine, mFlusiva, for adults 50 and over. This was its first time reviewing a new vaccine application since 2023." www.npr.org/2026/06/18/n...
www.npr.org
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
Key FDA committee unanimously recommends its first vaccine since 2023
2d
Dorit Reiss